ElevateBio CEO on disruptive potential for gene and cell therapies
David Hallal, ElevateBio CEO, joins 'Fast Money' to talk making CNBC's Disruptor 50 list, what is included in its portfolio, innovation in cell and gene therapy and more.
Видео ElevateBio CEO on disruptive potential for gene and cell therapies канала CNBC Television
Видео ElevateBio CEO on disruptive potential for gene and cell therapies канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Mad Money – 5/28/24 | Audio Only
Opening Bell, November 4, 2022
Office loan modifications jump: Trepp report
Breaking down shares of Hilton, Expedia and Match Group
Office loan modifications jump: Here’s what you need to know
Lockheed Martin sees record order volume in 2022 as earnings beat estimates
Cramer’s Mad Dash: Norwegian Cruise Line
VanEck CEO on the timeline for a spot Ethereum ETF
Jim Cramer looks at recent stock splits and their impacts on the market
Often when splits are announced the stock goes higher, says Jim Cramer
Finding investment opportunities as AI heads to mobile devices
Tug-of-war around the semi trade
ETF Edge, May 28, 2024
Detrick: Upward market bias is still intact
Nothing wrong with market leaders like Nvidia continuing to lead, says Trade Idea's Michael Nauss
Opening Bell: May 28, 2024
We are focused on our organic roadmap, says Box CEO
Clean Start: This clean-tech startup transforms carbon emissions into vodka
Neuberger's Kei Okamura on Japan market: Recent break in rally could be a good time to enter
Apple is a top teen pick, according to a Piper Sandler survey
Stock splits are bullish signals for companies, says Bank of America's Jared Woodard